NEW YORK (GenomeWeb) – Horizon Discovery today announced it will acquire Vienna-based cell engineering firm Haplogen Genomics.

The purchase is for an initial consideration of £6.0 million ($9.1 million) in cash and the issue of new ordinary shares with further potential earn-out payments based on future performance. The purchase consists of gross cash consideration of £3.0 million and the issue of new ordinary shares having an aggregate value of £3.0 million. The deal includes the potential for payments of stock worth up to £3.9 million based on future performance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.